Ankara Yıldırım Beyazıt University
Ankara, 06760, Turkey (Türkiye)
NCT Number: NCT06666244
This study aimed to evaluate the effect of carbohydrate quality on quality of life and menopausal symptoms in postmenopausal women. Data were collected from 604 postmenopausal women using a demographic questionnaire, the Menopause-Specific Quality of Life Questionnaire (MENQOL), and the Menopause Rating Scale (MRS). Carbohydrate quality was assessed using food frequency consumption data, and the results were analyzed with SPSS 24 software.
Looking for future studies?
Notify Me30 year–90 year
Female
Observational
Ankara, 06760, Turkey (Türkiye)
Objective: This study aimed to evaluate the effect of carbohydrate quality on quality of life and menopausal symptoms in postmenopausal women.
Method: A total of 604 postmenopausal women participated in the study. Participants completed a demographic questionnaire, the Menopause-Specific Quality of Life Questionnaire (MENQOL), and the Menopause Rating Scale (MRS). Carbohydrate quality was assessed using food frequency consumption data and analyzed based on dietary fiber, glycemic index, solid carbohydrate-to-total carbohydrate ratio, and whole grains-to-total grains ratio. Results were divided into five quartiles, with Q5 representing the highest and Q1 the lowest carbohydrate quality. Data analysis was conducted using SPSS 24 software.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Basaline
132 food groups obtained from the food consumption frequency questionnaire were analyzed. Daily intake (g/day) was calculated using the BeBiS program with a global database, based on the amount and frequency of food consumed by participants. Glycaemic Index (GI) values were also determined using the BeBiS program, taking into account both the amount and frequency of food consumed. To determine the Carbohydrate Quality Index score, each of the four components (fiber intake, whole grain ratio, Glycaemic Index, and total carbohydrate ratio) was rated from 1 to 5 points. The score for each component was then summed. Q5 indicates the highest and Q1 the lowest carbohydrate quality.
Time frame: Basaline
This scale is used to assess quality of life during menopause. It consists of 29 questions across four subdimensions, with scores ranging from 1 to 8. Higher scores on this scale indicate greater severity of complaints.
Time frame: Basaline
This scale was used to measure the severity and frequency of menopausal symptoms. It includes three subdimensions: psychological, somatic, and urogenital complaints. Each question has five response options (scored from 0 to 4), with a total possible score of 44 and a minimum score of 0. Higher scores indicate a greater negative impact on quality of life and an increase in symptoms.
Time frame: Basaline
Sociodemographic characteristics will be assessed using a structured questionnaire developed by the researchers. The questionnaire will include items on age, gender, education level, and income status. Results will be presented as frequencies and percentages for each characteristic.
Time frame: Basaline
Kilograms per square meter (kg/m2)
Time frame: Basaline
Body weight in kg
Time frame: Basaline
Height in cm
Ankara Yildirim Beyazıt University
Other
Evaluation of the Effect of Carbohydrate Quality on Quality of Life and Menopausal Symptoms in Postmenopausal Women
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06253403
Anorexia Nervosa, Feeding and Eating Disorders
Bratislava, Slovakia
View Trial DetailsNCT06429254
Neurologic Manifestations, Pain
Edirne, Turkey (Türkiye)
View Trial DetailsNCT06129279
Dysmenorrhea, Menstruation Disturbances
Karabük, Karabük Province, Turkey (Türkiye)
View Trial DetailsNCT05752110
Ketamine, Minor Surgical Procedure
Istanbul, Fatih, Turkey (Türkiye)
View Trial Details